Terns Pharmaceuticals, Inc. (TERN)

NasdaqGS - NasdaqGS Real-time price. Currency in USD

Add to watchlist

8.09

-0.11

(-1.34%)

As of 10:12AM EDT. Market open.

Major holders

Insider roster

Insider transactions

Currency in USD

Insider purchases - Last 6 months	Shares	Trans
Purchases	232,291	5
Sales	420,663	1
Net shares purchased (sold)	-188,372	6
Total insider shares held	1.16M	N/A
% net shares purchased (sold)	-14.00%	N/A

Net institutional purchases - Prior quarter to latest quarter	Shares
Net shares purchased (sold)	N/A
% change in institutional shares held	N/A

Insider transactions reported - last two years

Insider	Transaction	Type	Value	Date	Shares
YOON SEOKHO BRYAN Chief Operating Officer	Purchase at price 6.01 per share.	Direct	28,794	31 May 2024	4,791
VIVO OPPORTUNITY LLC Beneficial Owner of more than 10% of a Class of Security	Sale at price 6.20 - 6.99 per share.	Indirect	2,796,859	03 Apr 2024	420,663
YOON SEOKHO BRYAN Chief Operating Officer	Stock Award(Grant) at price 0.00 per share.	Direct	0	23 Jan 2024	68,750
VIGNOLA MARK J. Chief Financial Officer	Stock Award(Grant) at price 0.00 per share.	Direct	0	23 Jan 2024	68,750
QUIGLEY JILL M. Officer and Director	Stock Award(Grant) at price 0.00 per share.	Direct	0	23 Jan 2024	15,000
QUIRK ERIN M.D. Officer	Stock Award(Grant) at price 0.00 per share.	Direct	0	23 Jan 2024	75,000
YOON SEOKHO BRYAN Chief Operating Officer	Purchase at price 3.78 per share.	Direct	2,809	30 Nov 2023	743
QUIGLEY JILL M. Officer and Director	Stock Award(Grant) at price 0.00 per share.	Direct	0	15 Nov 2023	15,000
SUNDARAM SENTHIL VEL Chief Executive Officer	Purchase at price 10.61 per share.	Direct	22,398	31 May 2023	2,111
YOON SEOKHO BRYAN Chief Operating Officer	Purchase at price 10.61 per share.	Direct	106,068	31 May 2023	9,997
GORDON CARL L Director and Beneficial Owner of more than 10% of a Class of Security	Purchase at price 7.25 per share.	Indirect	1,000,000	23 Dec 2022	137,931
ORBIMED ADVISORS, L.L.C. Beneficial Owner of more than 10% of a Class of Security	Purchase at price 7.25 per share.	Indirect	1,000,000	23 Dec 2022	137,931
LU HONGBO B Director	Purchase at price 7.25 per share.	Indirect	5,499,995	23 Dec 2022	758,620
VIVO OPPORTUNITY LLC Beneficial Owner of more than 10% of a Class of Security	Purchase at price 7.25 per share.	Indirect	5,499,995	23 Dec 2022	758,620
SUNDARAM SENTHIL VEL Chief Executive Officer	Purchase at price 7.77 per share.	Direct	23	30 Nov 2022	3
YOON SEOKHO BRYAN Chief Operating Officer	Purchase at price 7.77 per share.	Direct	23	30 Nov 2022	3
VIGNOLA MARK J. Chief Financial Officer	Purchase at price 7.77 per share.	Direct	23	30 Nov 2022	3
LAV BIOSCIENCES FUND V LP Beneficial Owner of more than 10% of a Class of Security	Sale at price 5.50 per share.	Indirect	8,250,000	23 Nov 2022	1,500,000
LU HONGBO B Director	Purchase at price 3.60 per share.	Indirect	2,160,000	07 Sept 2022	600,000
VIVO OPPORTUNITY LLC Beneficial Owner of more than 10% of a Class of Security	Purchase at price 3.60 per share.	Indirect	2,160,000	07 Sept 2022	600,000
GORDON CARL L Director and Beneficial Owner of more than 10% of a Class of Security	Purchase at price 4.98 per share.	Indirect	18,376,200	16 Aug 2022	3,690,000
ORBIMED ADVISORS, L.L.C. Beneficial Owner of more than 10% of a Class of Security	Purchase at price 4.98 per share.	Indirect	18,376,200	16 Aug 2022	3,690,000
LU HONGBO B Director	Purchase at price 2.98 - 4.98 per share.	Indirect	10,821,962	16 Aug 2022	2,624,239
VIVO OPPORTUNITY LLC Beneficial Owner of more than 10% of a Class of Security	Purchase at price 2.98 - 4.98 per share.	Indirect	10,821,962	16 Aug 2022	2,624,239
YOON SEOKHO BRYAN Chief Operating Officer	Purchase at price 1.47 per share.	Direct	11,254	31 May 2022	7,656
VIGNOLA MARK J. Chief Financial Officer	Purchase at price 1.47 per share.	Direct	11,254	31 May 2022	7,656
GORDON CARL L Director and Beneficial Owner of more than 10% of a Class of Security	Purchase at price 17.00 per share.	Indirect	8,075,000	09 Feb 2021	475,000
GORDON CARL L Director and Beneficial Owner of more than 10% of a Class of Security		Indirect		09 Feb 2021	3,316,204
VIVO CAPITAL VIII, L.L.C. Beneficial Owner of more than 10% of a Class of Security	Purchase at price 17.00 per share.	Indirect	8,075,000	09 Feb 2021	475,000
VIVO CAPITAL VIII, L.L.C. Beneficial Owner of more than 10% of a Class of Security		Indirect		09 Feb 2021	2,200,133
ORBIMED ADVISORS, L.L.C. Director and Beneficial Owner of more than 10% of a Class of Security	Purchase at price 17.00 per share.	Indirect	8,075,000	09 Feb 2021	475,000
ORBIMED ADVISORS, L.L.C. Director and Beneficial Owner of more than 10% of a Class of Security		Indirect		09 Feb 2021	3,316,204
FLYNN JAMES E Beneficial Owner of more than 10% of a Class of Security	Purchase at price 17.00 per share.	Indirect	11,305,000	09 Feb 2021	665,000
FLYNN JAMES E Beneficial Owner of more than 10% of a Class of Security		Indirect		09 Feb 2021	1,717,033
LAV BIOSCIENCES FUND V LP Beneficial Owner of more than 10% of a Class of Security		Indirect		09 Feb 2021	4,781,566

NZX 5011,698.51-166.38(-1.40%)

NZD/USD0.6113-0.0032(-0.51%)

ALL ORDS7,943.60-31.20(-0.39%)

OIL79.08+0.63(+0.80%)

GOLD2,334.90-14.20(-0.60%)

Terns Pharmaceuticals, Inc. (TERN)

Insider transactions

Insider transactions reported - last two years

NZX 50
11,698.51
-166.38(-1.40%)

NZD/USD
0.6113
-0.0032(-0.51%)

ALL ORDS
7,943.60
-31.20(-0.39%)

OIL
79.08
+0.63(+0.80%)

GOLD
2,334.90
-14.20(-0.60%)